GlassScriptPhysician profile
Colette D Weber
NPI 1922042464
$2,235.19
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $407 · 2022: $808 · 2023: $1,020.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $859 · Education: $161.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $858.64 |
| Education | $161.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $378.50 | 2021-2023 | Taltz, Olumiant |
| Abbvie INC. | $298.62 | 2021-2023 | |
| Novo Nordisk INC | $231.32 | 2023 | Rybelsus, Ozempic |
| Amgen INC. | $223.61 | 2022-2023 | Prolia, Evenity |
| Janssen Scientific Affairs, LLC | $214.81 | 2022 | |
| Corcept Therapeutics | $157.07 | 2023 | Korlym |
| Horizon Therapeutics Plc | $133.63 | 2022-2023 | Tepezza |
| Glaxosmithkline, LLC. | $107.42 | 2021 | |
| Dexcom, INC. | $105.28 | 2023 | Dexcom G7 Gss (161) |
| Ucb, INC. | $75.81 | 2022 | |
| Novartis Pharmaceuticals Corporation | $72.65 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $72.32 | 2021-2023 | Farxiga |
| Radius Health, INC. | $56.48 | 2022 | |
| Insulet Corporation | $34.98 | 2023 | Omnipod |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.59 | 2023 | Jardiance |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $18.60 | 2023 | |
| Halozyme INC | $17.00 | 2023 | |
| Axsome Therapeutics, INC. | $13.50 | 2023 | Sunosi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Colette Weber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.